Benzalkonium chloride/octoxynol vaginal gel - Optima

Drug Profile

Benzalkonium chloride/octoxynol vaginal gel - Optima

Alternative Names: Alkyldimethylbenzylammonium chloride (ADBAC)/octoxynol - Optima; Benzalkonium chloride/octoxynol 9; Contraceptive gel - Optima Worldwide; Octoxynol 9/benzalkonium chloride; Octoxynol/benzalkonium chloride; Prevent-X; Surete

Latest Information Update: 01 Oct 2013

Price : $50 *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator Optima Worldwide
  • Developer OmniComm Systems; Optima Worldwide
  • Class Antiseptics; Benzylammonium compounds; Contraceptives; Polyethylene glycols; Quaternary ammonium compounds; Spermicidal contraceptives; Surfactants
  • Mechanism of Action Undefined mechanism
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity No

Highest Development Phases

  • Marketed Pregnancy
  • Discontinued HIV infections

Most Recent Events

  • 27 Dec 2000 Phase-III clinical trials for HIV infections prevention in Brazil (Vaginal)
  • 15 Dec 2000 Phase-III clinical trials for Contraception/Pregnancy (Prevention) in Brazil (Vaginal)
  • 22 Nov 2000 Launched for Contraception/Pregnancy (Prevention) in China (Vaginal)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top